US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist
  • 0.007500
  • -0.001200-13.79%
15min DelayClose Nov 29 13:00 ET
233.34KMarket Cap-375P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-117.09%-244.27K
-335.17%-48.25K
101.21%225
-571.26%-124.4K
25.09%-71.85K
93.30%-112.52K
113.72%20.52K
95.05%-18.59K
94.82%-18.53K
87.96%-95.92K
Net income from continuing operations
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
0.35%-3.71M
-19.56%-573.55K
77.31%-154.69K
-111.83%-2.62M
72.97%-357.67K
Operating gains losses
-96.74%88.93K
--0
----
----
----
21,398.69%2.73M
--330.93K
----
----
----
Depreciation and amortization
-55.37%72.32K
--0
--0
-18.65%32.86K
-8.62%39.46K
-18.37%162.06K
-18.60%38.49K
-18.09%39.99K
-20.16%40.39K
-16.67%43.19K
Other non cash items
-69.35%16.8K
--0
94.84%-123.71K
-94.62%129.06K
152.17%11.45K
-92.41%54.81K
1,090.89%45.78K
-6,088.10%-2.4M
--2.4M
--4.54K
Change In working capital
-71.92%133.16K
-115.73%-22.64K
223.26%60.89K
-69.27%74.12K
-84.99%20.79K
16.43%474.13K
-27.54%143.89K
-143.90%-49.4K
413.58%241.17K
181.75%138.47K
-Change in receivables
747.72%89.64K
-99.21%1.65K
149.33%120.15K
-438.19%-57.49K
842.43%25.32K
-111.20%-13.84K
268.20%210.03K
-908.01%-243.56K
66.42%17K
-89.75%2.69K
-Change in payables and accrued expense
-91.08%43.51K
63.27%-24.29K
-96.49%10.69K
-45.74%61.66K
-103.34%-4.53K
72.05%487.97K
-146.73%-66.14K
269.79%304.69K
209.27%113.64K
491.81%135.78K
Cash from discontinued investing activities
Operating cash flow
-117.09%-244.27K
-335.17%-48.25K
101.21%225
-571.26%-124.4K
25.09%-71.85K
93.30%-112.52K
113.72%20.52K
95.05%-18.59K
94.82%-18.53K
87.96%-95.92K
Investing cash flow
Cash flow from continuing investing activities
359.38%113.48K
0
94.67K
-19.03%20K
-1.2K
-2.09%24.7K
0
0
24.7K
0
Net PPE purchase and sale
--113.48K
--0
--114.67K
--0
---1.2K
--0
--0
--0
--0
--0
Net investment purchase and sale
--0
--0
---20K
----
----
--24.7K
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
359.38%113.48K
--0
--94.67K
-19.03%20K
---1.2K
-2.09%24.7K
--0
--0
--24.7K
--0
Financing cash flow
Cash flow from continuing financing activities
-72.49%27.51K
-98.06%1.26K
-91.60%1.26K
0
24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
19.98K
0
Net issuance payments of debt
-72.49%27.51K
-98.06%1.26K
-91.60%1.26K
--0
--24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
--19.98K
--0
Cash from discontinued financing activities
Financing cash flow
-72.49%27.51K
-98.06%1.26K
-91.60%1.26K
--0
--24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
--19.98K
--0
Net cash flow
Beginning cash position
10.37%129.7K
66.26%73.41K
-22.21%37.14K
278.00%81.65K
10.37%129.7K
-91.52%117.52K
-54.14%44.15K
-79.39%47.75K
-97.25%21.6K
-91.52%117.52K
Current changes in cash
-947.88%-103.28K
-154.93%-46.99K
2,773.26%96.16K
-499.26%-104.4K
49.90%-48.05K
100.96%12.18K
227.88%85.55K
97.34%-3.6K
104.71%26.15K
84.02%-95.92K
Effect of exchange rate changes
----
----
---59.89K
----
----
----
----
--0
----
----
End cash Position
-79.63%26.42K
-79.63%26.42K
66.26%73.41K
-22.21%37.14K
278.00%81.65K
10.37%129.7K
10.37%129.7K
-54.14%44.15K
-79.39%47.75K
-97.25%21.6K
Free cash flow
-118.15%-245.47K
-335.17%-48.25K
101.21%225
-571.26%-124.4K
23.85%-73.04K
93.31%-112.52K
113.62%20.52K
95.05%-18.59K
94.83%-18.53K
87.96%-95.92K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -117.09%-244.27K-335.17%-48.25K101.21%225-571.26%-124.4K25.09%-71.85K93.30%-112.52K113.72%20.52K95.05%-18.59K94.82%-18.53K87.96%-95.92K
Net income from continuing operations 81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K50.09%-178.52K0.35%-3.71M-19.56%-573.55K77.31%-154.69K-111.83%-2.62M72.97%-357.67K
Operating gains losses -96.74%88.93K--0------------21,398.69%2.73M--330.93K------------
Depreciation and amortization -55.37%72.32K--0--0-18.65%32.86K-8.62%39.46K-18.37%162.06K-18.60%38.49K-18.09%39.99K-20.16%40.39K-16.67%43.19K
Other non cash items -69.35%16.8K--094.84%-123.71K-94.62%129.06K152.17%11.45K-92.41%54.81K1,090.89%45.78K-6,088.10%-2.4M--2.4M--4.54K
Change In working capital -71.92%133.16K-115.73%-22.64K223.26%60.89K-69.27%74.12K-84.99%20.79K16.43%474.13K-27.54%143.89K-143.90%-49.4K413.58%241.17K181.75%138.47K
-Change in receivables 747.72%89.64K-99.21%1.65K149.33%120.15K-438.19%-57.49K842.43%25.32K-111.20%-13.84K268.20%210.03K-908.01%-243.56K66.42%17K-89.75%2.69K
-Change in payables and accrued expense -91.08%43.51K63.27%-24.29K-96.49%10.69K-45.74%61.66K-103.34%-4.53K72.05%487.97K-146.73%-66.14K269.79%304.69K209.27%113.64K491.81%135.78K
Cash from discontinued investing activities
Operating cash flow -117.09%-244.27K-335.17%-48.25K101.21%225-571.26%-124.4K25.09%-71.85K93.30%-112.52K113.72%20.52K95.05%-18.59K94.82%-18.53K87.96%-95.92K
Investing cash flow
Cash flow from continuing investing activities 359.38%113.48K094.67K-19.03%20K-1.2K-2.09%24.7K0024.7K0
Net PPE purchase and sale --113.48K--0--114.67K--0---1.2K--0--0--0--0--0
Net investment purchase and sale --0--0---20K----------24.7K--0--0--------
Cash from discontinued investing activities
Investing cash flow 359.38%113.48K--0--94.67K-19.03%20K---1.2K-2.09%24.7K--0--0--24.7K--0
Financing cash flow
Cash flow from continuing financing activities -72.49%27.51K-98.06%1.26K-91.60%1.26K024.99K-74.35%100K-56.61%65.03K-93.75%14.99K19.98K0
Net issuance payments of debt -72.49%27.51K-98.06%1.26K-91.60%1.26K--0--24.99K-74.35%100K-56.61%65.03K-93.75%14.99K--19.98K--0
Cash from discontinued financing activities
Financing cash flow -72.49%27.51K-98.06%1.26K-91.60%1.26K--0--24.99K-74.35%100K-56.61%65.03K-93.75%14.99K--19.98K--0
Net cash flow
Beginning cash position 10.37%129.7K66.26%73.41K-22.21%37.14K278.00%81.65K10.37%129.7K-91.52%117.52K-54.14%44.15K-79.39%47.75K-97.25%21.6K-91.52%117.52K
Current changes in cash -947.88%-103.28K-154.93%-46.99K2,773.26%96.16K-499.26%-104.4K49.90%-48.05K100.96%12.18K227.88%85.55K97.34%-3.6K104.71%26.15K84.02%-95.92K
Effect of exchange rate changes -----------59.89K------------------0--------
End cash Position -79.63%26.42K-79.63%26.42K66.26%73.41K-22.21%37.14K278.00%81.65K10.37%129.7K10.37%129.7K-54.14%44.15K-79.39%47.75K-97.25%21.6K
Free cash flow -118.15%-245.47K-335.17%-48.25K101.21%225-571.26%-124.4K23.85%-73.04K93.31%-112.52K113.62%20.52K95.05%-18.59K94.83%-18.53K87.96%-95.92K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data